Nexentis Technologies Inc. (NXTS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US80512Q6008
Nexentis Technologies Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -4.23 m USD |
| EBIT | -4.17 m USD |
| Net income | -4.00 m USD |
| Diluted EPS – continuing operations | -8.61 USD |
Full history since 2009, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Nexentis Technologies Inc.
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.The company was formerly known as N2OFF, Inc. and changed its name to Nexentis Technologies Inc. in February 2026. Nexentis Technologies Inc. was incorporated in 2009 and is headquartered in Ness Ziona, Israel.
More stocks
- SKINVISIBLE, INC. (SKVI)
- Maitong Sunshine Cultural Development Co., Ltd (MGSD)
- CEMTREX INC (CETX)
- Bravo Multinational Inc. (BRVO)
- OLENOX INDUSTRIES INC. (OLOX)
- Fortune Valley Treasures, Inc. (FVTI)
- Presidio Property Trust, Inc. (SQFT)
- Matinas BioPharma Holdings, Inc. (MTNB)
- Cybin Inc (HELP.NE)
- HEALTHY CHOICE WELLNESS CORP. (HCWC)
- ORAGENICS INC (OGEN)
- Kaya Holdings, Inc. (KAYS)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.